head-and-neck-cancer

Documents about head-and-neck-cancer

• Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy#900806ClinicalTrials.gov
• A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors#832695ClinicalTrials.gov
• Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR#374451HAL (France)
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck#828876ClinicalTrials.gov
• Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors.#209622NCBI PubMed Central
• Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer#1008745ClinicalTrials.gov
• A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation#1045459ClinicalTrials.gov
• Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible#916604ClinicalTrials.gov
• Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial#802804ClinicalTrials.gov
• S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer#883375ClinicalTrials.gov
• Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck#913192ClinicalTrials.gov
• S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors#804927ClinicalTrials.gov
• GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy#836993ClinicalTrials.gov
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery#877819ClinicalTrials.gov
• Data-driven biopsychosocial profiles to inform early psycho-oncology triage in head and neck cancer : A cross-sectional cluster analysis integrating patient-reported outcomes, medical complexity, and early psychosocial care utilization in an interdisciplinary fast-track diagnostic program.#823463NCBI PubMed Central
• Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC#845299ClinicalTrials.gov
• Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors#1007738ClinicalTrials.gov
• Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma#811183ClinicalTrials.gov
• 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients#859994ClinicalTrials.gov
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)#861036ClinicalTrials.gov
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer#805589ClinicalTrials.gov
• A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma#860683ClinicalTrials.gov
• The Next Frontier: Head and Neck Cancer Immunoprevention#614642eScholarship
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer#888910ClinicalTrials.gov
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer#859589ClinicalTrials.gov
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck#887235ClinicalTrials.gov
• Title XELOX FOR SALIVARY GLAND CANCERS#871183ClinicalTrials.gov
• Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx#897257ClinicalTrials.gov
• A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China#906979ClinicalTrials.gov
• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#978810ClinicalTrials.gov
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck#917831ClinicalTrials.gov
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer#851424ClinicalTrials.gov
• SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)#850530ClinicalTrials.gov
• S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer#849755ClinicalTrials.gov
• DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors#854313ClinicalTrials.gov
• Data Sheet 1_Designing and conducting interventional trials with passive-sensing applications on patient-owned smartphones: challenges and recommendations from the BD4QoL study.pdf#361741Figshare
• A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)#842721ClinicalTrials.gov
• Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer#784311eScholarship
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer#871278ClinicalTrials.gov
• Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer#864751ClinicalTrials.gov
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors#889138ClinicalTrials.gov
• Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells#888237ClinicalTrials.gov
• A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.#828040ClinicalTrials.gov
• Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer#979138ClinicalTrials.gov
• Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT#854377ClinicalTrials.gov
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer#904101ClinicalTrials.gov
• Association of race and ethnicity with quality of care among head and neck cancer patients in California#983433eScholarship
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer#890634ClinicalTrials.gov
• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study#411390ClinicalTrials.gov
• Benzydamine vs Supersaturated Calcium Phosphate Oral Rinses for Radiation Induced Oral Mucositis in Head and Neck Cancer Patients.#805620ClinicalTrials.gov